Viewing StudyNCT04714086



Ignite Creation Date: 2024-05-06 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04714086
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2023-09-25
First Post: 2021-01-14

Brief Title: Expanded Access Program for Avapritinib
Sponsor: Blueprint Medicines Corporation
Organization: Blueprint Medicines Corporation

Conditions & Keywords Data

Conditions:
Name
Solid Tumors
Keywords:
Name View
Gliomas View
Avapritinib View
BLU-285 View
Solid tumors View
Gastrointestinal stromal tumors GIST View